LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Direct Blood Dry LAMP Diagnoses African Trypanosomiasis

By LabMedica International staff writers
Posted on 08 Apr 2015
Print article
Image: Human African trypanosomes in a thin blood film (Photo courtesy of Dr. Myron G. Schultz).
Image: Human African trypanosomes in a thin blood film (Photo courtesy of Dr. Myron G. Schultz).
Loop-mediated isothermal amplification (LAMP) is a rapid and sensitive tool used for the diagnosis of a variety of infectious diseases, but still requires complicated sample preparation steps and a well-equipped laboratory to produce reliable and reproducible results.

Several substantial modifications to the LAMP technique have been made to carry out on-site diagnosis of Human African Trypanosomiasis (HAT) in remote areas where there are normally resource-poor laboratories in most developing countries.

Scientists at the Hokkaido University (Sapporo, Japan) working with colleagues in Zambia, refined an existing LAMP system for HAT diagnosis that is cost effective and stable at high temperature. In their system, lysed blood can be used directly with high detection sensitivity. This dry LAMP system will be widely applicable in the field or for bedside diagnosis even in areas lacking adequate infrastructure.

The first essential improvement was that LAMP reagents were dried and stabilized in a single tube by incorporating trehalose as a cryoprotectant to prolong shelf life at ambient temperature. The second technical improvement was achieved by simplifying the sample preparation step so that DNA or ribonucleic acid (RNA) could be amplified directly from detergent-lysed blood samples. Primer sets were evaluated by real-time LAMP and also melting curve analysis using the Rotor-Gene 3000 thermal cycler (Corbett Research, Sydney, Australia) to monitor the reaction, and optimal amplification time and temperature for primer sets were determined.

The investigators developed a combination of dyes that they have called a “colori-fluorometric indicator (CFI) for the LAMP reaction. They also developed a battery-driven hand-made light emitting diodes (LED) illuminator that emits 500 nm wavelength light, which was suitable for field or bedside use. Using CFI, the LAMP reactions could be detected in two ways: either by detecting amplified DNA products with GelGreen or by a decreased Magnesium (Mg2+) concentration with hydroxyl-naphtol blue (HNB). The resulting fluorescence was visible under a blue-green LED illuminator. The color of HNB changed from violet to blue during the progression of the LAMP reaction as the Mg2+ ion concentration decreased by forming insoluble magnesium pyrophosphate. These color changes were easily visible by the naked eye. The sensitivity, as determined by a ten-fold detection limit was comparable to that of calcein, a commonly used color-development reagent for LAMP.

The authors concluded that they had refined the HAT LAMP detection system, making the feasibility of LAMP for bedside diagnosis and field surveillance. Their LAMP system can be applied to a wide range of other infectious diseases and therefore paves the way for possible utilization of rapid molecular diagnostic tests at point of care stations in resource poor countries. Human African trypanosomiasis (HAT) is an endemic protozoan disease affecting many African countries, predominantly in rural areas where the tsetse fly vector is present. The study was published on March 13, 2015, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:

Hokkaido University 
Corbett Research 


Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
HIV-1 Test
HIV-1 Real Time RT-PCR Kit
New
Piezoelectric Micropump
Disc Pump

Print article

Channels

Molecular Diagnostics

view channel
Image: The study investigated D-dimer testing in patients who are at higher risk of pulmonary embolism (Photo courtesy of Adobe Stock)

D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism

Pulmonary embolism (PE) is a commonly suspected condition in emergency departments (EDs) and can be life-threatening if not diagnosed correctly. Achieving an accurate diagnosis is vital for providing effective... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more
Sekisui Diagnostics UK Ltd.